US$ 26.32
should i take glp 1 GLP-1 Medications Infographic Overcoming Judgment and Embracing Progress
Description
Consistent with these effects, GLP-1 RAs have been associated with substantial weight loss in clinical trials, leading to FDA approval of two of these agents liraglutide and semaglutide for chronic weight management in adults with obesity or with overweight and at least one weight-related comorbidity

Alicic, J.J
Ziyad Al-Aly, the study's lead author, wrote in The Conversation

Decisions are made with the prescribing clinician based on individual response

6 Multi-agonist strategies are increasingly being studied, some of which include dual GLP-1/GIP agonists like tirzepatide and triple agonists that target GLP-1, GIP, and glucagon-like retatrutide
